Interleukin-10 as a marker of disease progression in Dengue hemorrhagic fever
JCPSP-Journal of the College of Physicians and Surgeons Pakistan. 2016; 26 (3): 187-190
in English
| IMEMR
| ID: emr-177574
ABSTRACT
Objective:
To evaluate the plasma interleukin-10 [IL-10] levels in patients suffering from dengue hemorrhagic fever between 4 to 7 days of onset of disease and 24 hours after the first sample, to find out the association of plasma IL-10 levels with the outcome. StudyDesign:
Analytical study. Place and Duration of Study All major hospitals of Lahore, Pakistan, from August to November 2012
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Disease Progression
/
Severe Dengue
/
Patient Outcome Assessment
Limits:
Adult
/
Female
/
Humans
/
Male
Language:
English
Journal:
J. Coll. Physicians Surg. Pak.
Year:
2016
Similar
MEDLINE
...
LILACS
LIS